Cited Sources

The Lung Institute is a leading global provider of innovative regenerative technologies for the treatment of an array of debilitating pulmonary conditions. We are committed to an individualized patient-centric approach, consistently providing the highest quality of care and producing positive outcomes. Listed below are the references that we utilize to inform our patients about the lung diseases we treat, various resource information about the nature of cells and statistics for printed/online material.


*For more information, go to

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.